Natural Alternatives International, Inc. — Form 10-Q Summary
Business context and reporting period. This filing covers the three months ended September 30, 2023, the first quarter of fiscal 2024. NAI provides private-label supplement contract manufacturing and sells/licenses beta-alanine products under its CarnoSyn and SR CarnoSyn brands.
Financial performance and liquidity
| Metric | Quarter ended Sep. 30, 2023 | Prior-year quarter |
|---|---|---|
| Net sales | $34.0 million | $43.1 million |
| Gross profit / margin | $3.1 million / 9.2% | $5.4 million / 12.5% |
| Operating income (loss) | ($0.5 million) / (1.6%) | $1.5 million / 3.6% |
| Net income (loss) | ($0.7 million); ($0.12) per diluted share | $1.1 million; $0.18 per diluted share |
| Operating cash flow | $4.5 million provided | $4.6 million used |
| Capital expenditures | $1.3 million | $7.8 million |
- Cash and cash equivalents were $16.7 million at September 30, 2023. Working capital was $42.3 million; the current ratio was approximately 3.7.
- Term loan debt was $9.4 million; no revolving-line borrowings were outstanding, with $20.0 million available. NAI reported covenant compliance at quarter-end.
- Operating lease liabilities totaled approximately $46.9 million. Total liabilities increased to $71.4 million from $45.4 million, largely reflecting a $25.9 million lease remeasurement.
Changes versus the prior-year quarter
- Net sales fell 21%. Contract manufacturing sales declined 23% to $32.2 million, primarily as major customers reduced excess inventory. Patent and trademark licensing sales increased 32% to $1.8 million.
- Gross profit decreased 42%, and gross margin contracted 3.3 percentage points. Management cited lower manufacturing sales, unfavorable mix, and increased overhead costs, partly offset by lower labor and third-party processing costs.
- SG&A declined 4% to $3.7 million, but the lower sales base caused SG&A to rise to 10.8% of sales from 8.9%.
- Operating cash flow improved, aided principally by a $6.4 million cash inflow from lower inventory. Cash increased $3.1 million during the quarter.
Outlook, commentary, and risks
- NAI temporarily closed its Carlsbad high-speed powder-processing facility in August 2023 amid a major customer’s inventory-rebalancing efforts. Management expects operations to resume in the fourth quarter of fiscal 2024, but notes timing and future customer purchases are uncertain.
- Management anticipates a net loss in the first half of fiscal 2024, net income in the second half, and an overall fiscal 2024 net loss, subject to sales forecasts and the facility reopening. If customer inventory issues persist or forecasts are missed, revenue and profit could decline materially.
- Although compliant with credit covenants at September 30, NAI expects it may fail to meet some covenants in fiscal 2024’s second quarter because of weaker sales and the facility closure. It is negotiating a revised credit facility; successful completion and its terms are not assured.
- Customer concentration remains significant: three customers generated $26.4 million, approximately 78% of quarterly sales; the largest represented 36%. Management identifies dependence on a small number of customers and qualified raw-material suppliers as material risks.
- NAI extended its Vista manufacturing lease by ten years and five months beginning April 2024. Planned improvements include an approximately $2.3 million solar system; the landlord may reimburse up to $1.1 million of tenant improvements.
- Management is monitoring the Israel-Hamas conflict because NAI sources some raw materials from Israel. It is assessing alternative sourcing and safety-stock options; broader geopolitical, shipping, and currency risks also remain.
- No material pending legal proceeding was reported as of November 9, 2023. Management concluded disclosure controls were effective as of quarter-end.
Important facts for investors to verify
- Whether the Carlsbad facility reopens as expected in fiscal Q4 2024 and whether the key customer resumes orders.
- Progress, terms, and timing of negotiations for a revised credit facility, including covenant compliance and continued access to the $20.0 million line.
- Subsequent-quarter sales, gross margins, and customer concentration relative to management’s fiscal-year outlook.
- Whether inventory reductions and supplier or geopolitical disruptions affect production, customer demand, or cash generation.
- Lease-improvement spending, landlord reimbursements, and the resulting impact on capital requirements and lease obligations.